Evidence map›Paper›PMID 25926416›Full record

Trial reportThe Journal of nutrition2015

Prenatal Supplementation with Docosahexaenoic Acid Has No Effect on Growth through 60 Months of Age.

Ines Gonzalez-Casanova, Aryeh D Stein, Wei Hao, Raquel Garcia-Feregrino, Albino Barraza-Villarreal, Isabelle Romieu, Juan A Rivera, Reynaldo Martorell, Usha Ramakrishnan

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00646360 (Effects of Prenatal DHA Supplements on Infant Development), which is not on this map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00646360 nacompletednot on this map

Effects of Prenatal DHA Supplements on Infant Development

TypeinterventionalSponsorEmory UniversityRan2005 to 2014Enrolled1,094ConditionsPregnancyArmsDHA, Placebo
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Omega-3 fatty acid addition during pregnancy.The Cochrane database of systematic reviews · 2018
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Ines Gonzalez-CasanovaHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA;
Aryeh D SteinHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA;
Wei HaoHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA;
Raquel Garcia-FeregrinoHealth and Nutrition Research Center and.
Albino Barraza-VillarrealPopulation Health Research Center, National Institute of Public Health, Cuernavaca, Mexico; and.
Isabelle RomieuInternational Agency for Research on Cancer, Lyon, France.
Juan A RiveraHealth and Nutrition Research Center and.
Reynaldo MartorellHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA;
Usha RamakrishnanHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA; uramakr@emory.edu.
Emory University · USNutrition Sciences (Belgium) · BECentre international de recherche sur le cancer · FRNational Institute of Public Health · SI

Funding

Effect of Prenatal DHA Supplements on Infant DevelopmentR01HD043099 · NICHD · EMORY UNIVERSITY · PI RAMAKRISHNAN, USHA · 2004 to 2012
$4.1M
Omega fatty acid supplementation and allergic diseases in childrenR01HD058818 · NICHD · MEXICO NATIONAL INSTITUTE OF PUBLIC HLTH · PI ROMIEU, ISABELLE · 2009 to 2012
$768k
NICHD NIH HHS HD-043099NICHD NIH HHS HD-058818NICHD NIH HHS R01 HD043099World Health Organization 001
6 · The paper itself

Abstract

backgroundPrenatal supplementation with docosahexaenoic acid (DHA) has been shown to increase birth size, but it is unclear whether these differences translate into improved postnatal growth.

objectiveWe assessed the effect of prenatal supplementation with DHA on offspring weight, length, and body mass index (BMI) through 60 mo of age.

methodsWe examined growth patterns (height, weight, and BMI) in a cohort of 802 Mexican children whose mothers participated in a randomized, controlled trial of daily supplementation with 400 mg/d of DHA or a placebo from week 18-22 of gestation through delivery, with the use of a longitudinal multilevel model of growth.

resultsOverall, means ± SDs of height-, weight-, and BMI-for-age z scores relative to WHO growth standards at 60 mo were -0.49 ± 0.91, -1.15 ± 1.07 and 0.13 ± 1.11, respectively. There were no significant differences by treatment group (all P > 0.05) for height, weight, or BMI at any age through 60 mo. Similarly, DHA did not affect the average growth or the trajectories for these measures through 60 mo.

conclusionPrenatal DHA supplementation did not affect height, weight, or BMI through 60 mo of age. This trial was registered at clinicaltrials.gov as NCT00646360.

Indexed as

Dietary SupplementsPrenatal CareAdultBody Mass IndexBody WeightChild DevelopmentChild, PreschoolDocosahexaenoic AcidsDouble-Blind MethodFemaleGrowth ChartsHumansInfantMaleMexicoWorld Health OrganizationDocosahexaenoic Acidschild developmentchild growthdocosahexaenoic acidmaternal and child healthpolyunsaturated fatty acidsprenatal supplementation

Identifiers

PMID25926416
PMCPMC4442112
OpenAlexW2022900143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.